Docusign Inc. (NASDAQ:DOCU – Get Free Report) Director Anna Marrs sold 363 shares of the firm’s stock in a transaction on Friday, June 5th. The shares were sold at an average price of $49.42, for a total transaction of $17,939.46. Following the completion of the transaction, the director directly owned 12,977 shares of the company’s stock, valued at $641,323.34. This represents a 2.72% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Anna Marrs also recently made the following trade(s):
- On Tuesday, June 2nd, Anna Marrs sold 365 shares of Docusign stock. The shares were sold at an average price of $55.04, for a total transaction of $20,089.60.
Docusign Stock Performance
NASDAQ:DOCU opened at $47.26 on Monday. Docusign Inc. has a 1-year low of $40.16 and a 1-year high of $86.65. The firm has a fifty day simple moving average of $47.76 and a 200 day simple moving average of $54.09. The stock has a market capitalization of $9.18 billion, a PE ratio of 30.69, a P/E/G ratio of 1.80 and a beta of 0.92.
Docusign announced that its board has authorized a share buyback program on Tuesday, March 17th that permits the company to buyback $2.00 billion in shares. This buyback authorization permits the company to reacquire up to 21% of its shares through open market purchases. Shares buyback programs are typically a sign that the company’s board believes its shares are undervalued.
Wall Street Analysts Forecast Growth
A number of equities research analysts have recently weighed in on the company. UBS Group set a $60.00 target price on Docusign in a report on Friday. Wedbush dropped their target price on Docusign from $60.00 to $58.00 and set a “neutral” rating for the company in a report on Friday. Royal Bank Of Canada dropped their target price on Docusign from $70.00 to $55.00 and set a “sector perform” rating for the company in a report on Wednesday, March 18th. Wells Fargo & Company dropped their target price on Docusign from $60.00 to $55.00 and set an “equal weight” rating for the company in a report on Friday. Finally, JPMorgan Chase & Co. dropped their target price on Docusign from $78.00 to $65.00 and set a “neutral” rating for the company in a report on Wednesday, March 18th. Three investment analysts have rated the stock with a Buy rating, fifteen have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $60.27.
Get Our Latest Research Report on Docusign
Institutional Inflows and Outflows
Hedge funds and other institutional investors have recently bought and sold shares of the stock. Central Pacific Bank Trust Division acquired a new position in Docusign in the fourth quarter valued at about $25,000. Modus Advisors LLC acquired a new position in Docusign in the fourth quarter valued at about $27,000. Torren Management LLC acquired a new position in Docusign in the fourth quarter valued at about $28,000. Aventura Private Wealth LLC acquired a new position in Docusign in the fourth quarter valued at about $30,000. Finally, True Wealth Design LLC raised its stake in Docusign by 105.2% in the fourth quarter. True Wealth Design LLC now owns 433 shares of the company’s stock valued at $30,000 after purchasing an additional 222 shares in the last quarter. Institutional investors and hedge funds own 77.64% of the company’s stock.
Key Docusign News
Here are the key news stories impacting Docusign this week:
- Positive Sentiment: DocuSign beat first-quarter expectations, posting adjusted EPS of $1.09 versus $1.00 expected and revenue of $830.2 million versus $823.2 million estimated, with sales up 8.7% year over year. DocuSign Beats Fiscal Q1 Estimates, but IAM Traction Remains in Focus, RBC Says
- Positive Sentiment: The company said adoption of its AI-powered Intelligent Agreement Management platform is improving, and it raised full-year revenue guidance slightly, indicating demand remains healthy. DocuSign Nudges Revenue Outlook Higher After First-Quarter Profit Rises
- Neutral Sentiment: Analyst commentary remains mixed, with Wedbush lowering its price target to $58 from $60 while keeping a neutral rating, and BTIG cutting its target to $60 from $70 but maintaining a buy rating.
- Neutral Sentiment: DocuSign also highlighted AI integrations, including ChatGPT and Codex, and continued share repurchases, which support the long-term story but were not enough to offset near-term guidance concerns. Docusign Inc (DOCU) Q1 2027 Earnings Call Highlights
- Negative Sentiment: Shares moved lower because the full-year outlook did not meaningfully exceed Wall Street expectations, dampening enthusiasm despite the earnings beat and prompting a “sell-the-news” reaction. DocuSign shares fall despite Q1 beat as guidance disappoints investors
- Negative Sentiment: Investors also appear to be focusing on whether DocuSign can accelerate growth beyond the low-double-digit range, as recent reports say the outlook “left investors looking for stronger signs of accelerating growth.” DocuSign stock falls as cautious outlook overshadows earnings beat
Docusign Company Profile
DocuSign, Inc (NASDAQ: DOCU) is a leading provider of electronic signature and digital transaction management solutions. The company’s flagship offering, DocuSign eSignature, enables organizations to send, sign and manage legally binding electronic agreements securely in the cloud. Beyond eSignature, DocuSign’s Agreement Cloud combines contract lifecycle management, document generation, and workflow automation to streamline agreement processes from initiation through execution and storage.
DocuSign’s platform serves a diverse customer base spanning industries such as finance, real estate, healthcare, technology, and government.
See Also
- Five stocks we like better than Docusign
- These 3 Insurance Stocks Made New 52-Week Highs: Still Time to Buy?
- 3 Stocks Under $20 to Buy Before a Broader Market Rally
- Petco Faces Tough Competition, But Momentum Is Building
- The Lock-In Effect Is Real—These 3 Homebuilders Are Betting on It
Receive News & Ratings for Docusign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Docusign and related companies with MarketBeat.com's FREE daily email newsletter.
